A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care (ISABELA1)

Investigator: Sandeep Sahay, MD

Study Coordinator: Royanne Holy

Status: Enrolling

ClinicalTrials.gov Number: NCT03711162

Phone: 713.363.7536

Protocol Number: Pro00020856


The main purpose of this study is to see how GLPG1690 works together with your current standard treatment on your lung function and IPF disease in general. The study will also investigate how well GLPG1690 is tolerated (for example if you get any side effects while on study drug).
More to Explore